Dr. Tori Hudson graduated from the National College of Naturopathic Medicine (NCNM) in 1984 and has served the college in many capacities. She is currently clinical professor at NCNM and Bastyr University, has been in practice for over 31 years, and is medical director of the clinic A Woman’s Time in Portland, Oregon. She is the author of the book Women’s Encyclopedia of Natural Medicine; a contributing author to several books, including the Textbook of Natural Medicine; and director of research and education for Vitanica, a supplement company for women. She is a nationally recognized author, speaker, educator, researcher, and clinician.
Notes
1. Kessler R, Soukup J, Davis R, et al. The use of complementary and alternative therapies to treat anxiety and depression in the United States. Am J Psychiatry. 2001;158:289–294.
2. Smit E, Muskiet F, Boersma E. The possible role of essential fatty acids in the pathophysiology of malnutrition: a review. Prostaglandins Leukot Essent Fat Acids. 2004;71(4):241–250.
3. Hibbeln J. Fish consumption and major depression. Lancet. April 18, 1998;351:1213.
4. Tanskanen A, Hibbeln J, Hintikka J, et al. Fish consumption and depression and suicidality in a general population. Arch Gen Psychiatry. 2001;58:512–513.
5. Hirayama T. Life-style and mortality: a large census-based cohort study in Japan. Basel: Karger; 1990.
6. Adams P, Lawson S, Sanigorski A, Sinclair A. Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids. 1996;31:157–161.
7. McNamara R, Jandacek R, Rider T, et al. Selective deficits in erythrocyte docosahexaenoic acid composition in adult patients with bipolar disorder and major depressive disorder. J Affect Disord. 2010;126:303–311.
8. Weidner G, Connor S, Hollis J, Connor W. Improvements in hostility and depression in relation to dietary change and cholesterol lowering. Ann Intern Med. 1992;117:820–823.
9. Booth-Kewley S, Friedman HS. Psychological predictors of heart disease: a quantitative review. Psychol Bull. 1987;101(3):343–362.
10. Salem N, Ward G. The effects of ethanol on polyunsaturated fatty acid composition. In: Alling C, Diamond I, Leslie S, Sun G, Wood W, eds. Alcohol, Cell Membranes, and Signal Transduction in Brain. New York: Plenum Press, 1993:33–46.
11. Poudel-Tandukar K, Nanri A, Iwasaki M, et al. Long chain n-3 fatty acids intake, fish consumption and suicide in a cohort of Japanese men and women– The Japan Public Health Center-based prospective study. J Affect Disord. 2011;129:282–288.
12. Appleton K, Hayward R, Gunnell D, et al. Effects of n-3 long-chain polyunsaturated fatty acids on depressed mood: systematic review of published trials. Am J Clin Nutr. 2006;84(6):1308–1316.
13. Ross B, Seguin J, Sieswerda L. Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid? Lipids Health Dis. Sept. 18, 2007;6:21.
14. Lin P, Su K. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J Clin Psychiatry. 2007;68(7):1056–1061.
15. Freeman M, Hibbeln J, Wisner K, et al. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry. 2006;67(12):1954–1967.
16. Williams A, Katz D, Ali A, et al. Do essential fatty acids have a role in the treatment of depression. J Affect Disord. 2006;93:117–123.
17. Stoll A, Severus W, Freeman M, et al. Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry. 1999;56:407–412.
18. Maes M, Christophe A, Delanghe J, et al. Lowered omega 3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res. 1999;85:275–291.
19. Edwards R, Peet M, Shay J, Horrobin D. Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J Affect Disord. 1998;48(2–3):149–155.
20. Peete M, Murphy B, Shay J, Horrobin D. Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry. 1998;43(5):315–319.
21. Horrocks L, Yeo Y. Health benefits of docosahexaenoic acid (DHA). Pharmacol Res. 1999;22(5–6):474–480.
22. Bruinsma K, Taren D. Dieting, essential fatty acid intake, and depression. Nutr Rev. 2000;58(4):98–108.
23. Su K, Huang S, Chiu C, Shen W. Omega-3 fatty acids in major depressive disorder–a preliminary double-blind, placebo-controlled trial. Eur Neuropsychopharmacol. 2003;13:267–271.
24. Peet M, Horrobin D. A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry. 2002;59 (10):913–319.
25. Nemets B, Stahl Z, Belmaker R. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry. 2002;159:477–479.
26. Gertsik L, Poland R, Bresee C, et al. Omega-3 fatty acid augmentation of citalopram treatment for patients with major depressive disorder. J Clin Psychopharmacol. 2012;32(1):61–64.
27. Freeman M, Hibbeln J, Silver M, et al. Omega-3 fatty acids for major depressive disorder associated with the menopausal transition: preliminary open trial. Menopause. 2011 18(3):279–284.
28. Lesperance F, Frasure-Smith N, St-Andre E, et al. The efficacy of omega-3 supplementation for major depression: a randomized controlled trial. J Clin Psychiatry. 2011;72(8):1054–1062.
29. Marangell L, Martinez J, Zboyan H, et al. A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am J Psychiatry. 2003;160 (5):996–998.
30. Mischoulan D, Best-Popescu C, Laposata M, et al. A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder. Eur Neuropsychopharmacol. 2008;18:639–645.
31. Haberka M, Mizia-Stec K, Mizia M, et al. Effects of n-3 polyunsaturated fatty acids on depressive symptoms, anxiety and emotional state in patients with acute myocardial infarction. Pharmacol Rep. 2013;65:59–68.
32. Mozaffari-Khosravi H, Yassini-Ardakani M, Karamati M, et al. Eicosapentaenoic acid versus docosahexaenoic acid in mild-to moderate depression: A randomized, double-blind, placebo-controlled trial. Eur Neuropsychopharmacol. 2013;23:636–644.
33. Jazayeri S, Tehrani-Doost M, Keshavarz SA, et al. Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder. Aust N Z J Psychiatry. 2008 Mar;42(3):192–198.
34. Grosso G, Pajak A, Maventano S, et al. Role of omega fatty acids in the treatment of depressive disorders. A comprehensive meta-analysis of randomized controlled trials. PLOS One. 2014;9(5):e96905.









0 Comments